Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 18 (2) , 2269-2275
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Use of self‐controlled designs in pharmacoepidemiologyJournal of Internal Medicine, 2014
- The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experimentsStatistics in Medicine, 2013
- The incident user design in comparative effectiveness researchPharmacoepidemiology and Drug Safety, 2012
- Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of StatinsAmerican Journal of Epidemiology, 2012
- Surveillance Bias in Outcomes ReportingJAMA, 2011
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 2011
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for PhysiciansJournal of General Internal Medicine, 2011
- Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity‐score matched samplesStatistics in Medicine, 2009
- Replicated studies of two randomized trials of angiotensin‐ converting enzyme inhibitors: further empiric validation of the ‘prior event rate ratio’ to adjust for unmeasured confounding by indicationPharmacoepidemiology and Drug Safety, 2008
- A meta-analysis of the association between adherence to drug therapy and mortalityBMJ, 2006